NCT06257901

Brief Summary

Currently, treatments for Fabry disease are pharmacological and predominantly focus on the physical symptoms of the disease. In the general population and individuals with disabilities, increasing physical activity levels and reducing sedentary time can be an effective, non-pharmacological treatment to improve mental health and quality of life. Such interventions have not yet been developed or evaluated in people with Fabry disease. The aim of this study is to co-design a physical activity and sedentary behaviour intervention tailored to the needs of adults with Fabry disease. The study will seek to gain the expertise of adults with Fabry disease, specialist stakeholders (physicians, cardiologists and clinical nurse specialists) and lay specialist stakeholders (family and friends of adults with Fabry disease and members of staff and volunteers at the Society for Mucopolysaccharide Diseases). A range of views and experiences of physical activity and sedentary behaviour will be explored via focus groups (with individuals with Fabry disease and lay specialist stakeholders) and semi-structured interviews (with specialist stakeholders). The information gathered from the focus groups and interviews will then be utilised to inform participatory workshops (with individuals with Fabry disease) to test intervention concepts. Data from these activities will inform the design of a future intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 25, 2024

Completed
20 days until next milestone

First Posted

Study publicly available on registry

February 14, 2024

Completed
16 days until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
Last Updated

February 13, 2025

Status Verified

February 1, 2025

Enrollment Period

7 months

First QC Date

January 25, 2024

Last Update Submit

February 11, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Focus groups (adults with Fabry disease)

    Themes describing adults with Fabry disease's views and experiences of physical activity and sedentary behaviour- Emergence of themes describing participants' views and experiences from analysis of focus groups (using the Framework Method).

    9 months

  • Focus groups (lay specialist stakeholders)

    Themes describing lay specialist stakeholders' views and experiences of physical activity and sedentary behaviour- Emergence of themes describing participants' views and experiences from analysis of focus groups (using the Framework Method).

    9 months

  • Semi-structured interviews (specialist stakeholders)

    Themes describing specialist stakeholders' views and experiences of physical activity and sedentary behaviour- Emergence of themes describing participants' views and experiences from analysis of interviews (using the Framework Method).

    9 months

  • Participatory workshops (adults with Fabry disease)

    Themes describing adults with Fabry disease's views and experiences of initial intervention concepts- Emergence of themes describing participants' views and experiences from analysis of participatory workshops (using the Framework Method).

    9 months

Study Arms (3)

Adults with Fabry disease

Focus groups and participatory workshops

Other: Interviews/Focus groups/Participatory workshops

Lay specialist stakeholders

Focus groups

Other: Interviews/Focus groups/Participatory workshops

Specialist stakeholders

Interviews

Other: Interviews/Focus groups/Participatory workshops

Interventions

Qualitative study (no intervention delivered)

Adults with Fabry diseaseLay specialist stakeholdersSpecialist stakeholders

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults with Fabry disease, lay specialist stakeholders and specialist stakeholders who meet the eligibility criteria.

You may qualify if:

  • Have been diagnosed with Fabry disease.
  • Aged ≥ 18 years old.
  • Able to independently ambulate with or without the use of a walking aid.
  • Lives in the United Kingdom.
  • Deemed eligible to participate following screening by a clinician (for participatory workshops).
  • The circumstances in which an individual may be deemed ineligible to participate in the participatory workshops based on the clinician's assessment are as follows:
  • Severe neuropathic pain.
  • Stage 4 heart failure or other condition resulting in breathlessness to a level they cannot participate.
  • Other clinical condition which dominates the clinical picture to the extent that it dominates the symptoms and biases the results.

You may not qualify if:

  • Incapacity to provide written informed consent.
  • Unable to communicate in English to a sufficient level to permit engagement in the study.
  • Specialist stakeholders will be members of staff at NHS specialist centres for Fabry disease who are directly involved in the healthcare of adults with Fabry disease.
  • Lay specialist stakeholders will be individuals who have been involved in supporting adults with Fabry disease, such as family, friends and members of staff at the Society for Mucopolysaccharide Diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brunel University London

London, United Kingdom

Location

MeSH Terms

Conditions

Fabry Disease

Interventions

Interviews as Topic

Condition Hierarchy (Ancestors)

SphingolipidosesLysosomal Storage Diseases, Nervous SystemBrain Diseases, Metabolic, InbornBrain Diseases, MetabolicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCerebral Small Vessel DiseasesCerebrovascular DisordersVascular DiseasesCardiovascular DiseasesGenetic Diseases, X-LinkedGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesMetabolism, Inborn ErrorsLipidosesLipid Metabolism, Inborn ErrorsLysosomal Storage DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesLipid Metabolism Disorders

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Lecturer in Sport, Health and Exercise Sciences

Study Record Dates

First Submitted

January 25, 2024

First Posted

February 14, 2024

Study Start

March 1, 2024

Primary Completion

September 30, 2024

Study Completion

September 30, 2024

Last Updated

February 13, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations